Mr. Friedman has served as a member of the Board of Directors of Deciphera Pharmaceuticals since November 2019. Mr. Friedman has over 40 years of experience in the professional services industry. Mr. Friedman currently serves as Chief Executive Officer at IPFS Inc., a privately held finance company. Previously, Mr. Friedman worked for Deloitte Touche Tohmatsu Limited (Deloitte), a global services organization, from 1979 until his retirement from Deloitte in November 2019. During this time, Mr. Friedman served in several senior officer positions at Deloitte, including as the global Chief Operating Officer from June 2015 through June 2019; Deloitte’s U.S. Chief Operating Officer, from June 2015 to June 2017; Deloitte’s U.S. Chief Financial Officer, from June 2011 through May 2016, and the Interim U.S. Chief Executive Officer, from 2014 to 2015. Mr. Friedman received his B.A. in Accounting and Business Administration from the University of Kansas.